» Articles » PMID: 36958334

SARS-CoV-2 Breakthrough Infection Induces Rapid Memory and De Novo T cell Responses

Abstract

Although the protective role of neutralizing antibodies against COVID-19 is well established, questions remain about the relative importance of cellular immunity. Using 6 pMHC multimers in a cohort with early and frequent sampling, we define the phenotype and kinetics of recalled and primary T cell responses following Delta or Omicron breakthrough infection in previously vaccinated individuals. Recall of spike-specific CD4 T cells was rapid, with cellular proliferation and extensive activation evident as early as 1 day post symptom onset. Similarly, spike-specific CD8 T cells were rapidly activated but showed variable degrees of expansion. The frequency of activated SARS-CoV-2-specific CD8 T cells at baseline and peak inversely correlated with peak SARS-CoV-2 RNA levels in nasal swabs and accelerated viral clearance. Our study demonstrates that a rapid and extensive recall of memory T cell populations occurs early after breakthrough infection and suggests that CD8 T cells contribute to the control of viral replication in breakthrough SARS-CoV-2 infections.

Citing Articles

Muscle macrophage regenerative response after squalene-adjuvanted influenza vaccination drives Th2-skewed response and is reduced with age.

Noureddine M, Chang L, Chang L, El Ayache F, El-Ayache F, Laghlali G Res Sq. 2025; .

PMID: 39975920 PMC: 11838721. DOI: 10.21203/rs.3.rs-5760877/v1.


Robust mucosal SARS-CoV-2-specific T cells effectively combat COVID-19 and establish polyfunctional resident memory in patient lungs.

Zhu A, Chen Z, Yan Q, Jiang M, Liu X, Li Z Nat Immunol. 2025; 26(3):459-472.

PMID: 39875584 PMC: 11876067. DOI: 10.1038/s41590-024-02072-9.


Maternal-fetal cytokine profiles in acute SARS-CoV-2 "breakthrough" infection after COVID-19 vaccination.

Packer C, Jasset O, Hanniford N, Brigida S, Demidkin S, Perlis R Front Immunol. 2025; 15:1506203.

PMID: 39845965 PMC: 11750656. DOI: 10.3389/fimmu.2024.1506203.


Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters.

Da Silva Antunes R, Fajardo-Rosas V, Yu E, Galvez R, Abawi A, Escarrega E bioRxiv. 2025; .

PMID: 39829792 PMC: 11741356. DOI: 10.1101/2025.01.08.631842.


Vaccine-induced T cell responses control Orthoflavivirus challenge infection without neutralizing antibodies in humans.

Kalimuddin S, Tham C, Chan Y, Hang S, Kunasegaran K, Chia A Nat Microbiol. 2025; 10(2):374-387.

PMID: 39794472 PMC: 11790491. DOI: 10.1038/s41564-024-01903-7.


References
1.
Kedzierska K, Thomas P . Count on us: T cells in SARS-CoV-2 infection and vaccination. Cell Rep Med. 2022; 3(3):100562. PMC: 8872824. DOI: 10.1016/j.xcrm.2022.100562. View

2.
Koutsakos M, Lee W, Reynaldi A, Tan H, Gare G, Kinsella P . The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants. Immunity. 2022; 55(7):1316-1326.e4. PMC: 9135796. DOI: 10.1016/j.immuni.2022.05.018. View

3.
Koutsakos M, Nguyen T, Kedzierska K . With a Little Help from T Follicular Helper Friends: Humoral Immunity to Influenza Vaccination. J Immunol. 2019; 202(2):360-367. DOI: 10.4049/jimmunol.1800986. View

4.
Weinreich D, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R . REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19. N Engl J Med. 2021; 385(23):e81. PMC: 8522800. DOI: 10.1056/NEJMoa2108163. View

5.
Puhach O, Adea K, Hulo N, Sattonnet P, Genecand C, Iten A . Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2. Nat Med. 2022; 28(7):1491-1500. DOI: 10.1038/s41591-022-01816-0. View